Activity value 79pakistan Buyer&Supplier,Last transaction date:
2026-06-09Address: h no 489 st 9 g 10/1 islamabad.
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for nawal pharmaceuticals from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 32 transactions, with a transaction quantity of 52084.74 and a transaction weight of 0.
YearTransactionsQuantityWeight
202559185326.950
20263252084.740
Bill of lading data
<
1/15
>
Trade date
2026/06/09
B/L No.
——
Suppliers
.henan capital imports export trading co.ltd.
Buyers
nawal pharmaceuticals
POLs
——
PODs
kapw
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
12631.088753
Hs code
29335940
Product tags
norfloxacin base,pharmaceutical raw material
Product description
NORFLOXACIN BASE (PHARMACEUTICAL RAW MATERIAL)
Expand
nawal pharmaceuticals is pakistan Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,active pharmaceutical ingredient,oxytetracycline hcl.
According to the 52wmb.com global trade database, as of 2026-06-09, the company has completed 578 international trades,
with its main trading regions covering other,china,costa rica etc.
The core products include HS29419090,HS29413000,HS29335990 etc,
often transported via kapw,port kape, port mcc appraisement karachi west import etc,
and its main trading partners are xian rongzhi industries trade co.ltd.,fipharm,shandong lukang shelile pharmaceu co.ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on nawal pharmaceuticals is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.